Delivery Order SPE2DB22D9101-SPE2DB24FU7NP

Award Date 8/14/24
Potential Completion Date 9/5/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,844.40, is for the delivery of BOTOX 100 unit vials and has an ultimate completion date of September 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,688.80 contract is for the delivery of 100-unit vials of Botox, with a period of performance through August 20, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,229.60 contract was awarded on September 11, 2024 by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, with an ultimate completion date of October 2, 2024. The contract is for the delivery of 100-unit vials of the pharmaceutical product BOTOX. This award is part of a larger, single-award...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $2,768.88 and provides for the delivery of 100-unit vials of BOTOX to support the recurring medical supply needs of military health facilities. The contract is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,845.92 and an ultimate completion date of April 17, 2024. DMS Pharmaceutical Group is supplying Botox 100 unit vials to the DLA under this delivery order, which is part of a larger indefinite delivery contract (IDC) between the company and...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $4,614.80, is for the delivery of BOTOX 100 unit vials to support the recurring pharmaceutical supply needs of military health facilities. The order is part of a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which runs through December 31, 2025. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Botox 200-unit vials, with a ceiling value of $1,940.55 and a completion date of March 1, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,537.76 contract is to provide BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which...
This is a $2,754.30 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the delivery of 4,568,221,803 units of Botox 200 unit vials, with a period of performance through May 28, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $34,611.00, is for the delivery of BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
  • SPE2DB22D9101
    Indefinite Delivery Contract
  • SPE2DB22D9101-SPE2DB24FU7NP
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,768.88 contract is for the delivery of BOTOX 100 unit vials and has a completion date of September 5, 2024.

The award is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which enables the agency to place orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military healthcare facilities worldwide. This IDC allows DMS Pharmaceutical Group to serve as a prime vendor for the distribution of both routine and specialized medications to the Department of Defense. The contract has no set-aside designation.

Generated 11/13/24, 9:04 AM